Autism Spectrum Disorders

Rutter's Child and Adolescent Psychiatry: Fifth Edition

Volumn , Issue , 2009, Pages 759-781

  Van Engeland, Herman ^a   Buitelaar, Jan K ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autism spectrum disorders (ASD); Classification; Clinical characteristics; Cognitive theories; Course of autism; Differential diagnosis and assessment; Epidemiology; Predictors of outcome; Treatment and etiology

Indexed keywords

EID: 84889301839     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444300895.ch46     Document Type: Chapter

References (86)

1. Leff, J., & Vaughn, C. (1985). Expressed emotion in families: Its significance for mental illness. Guilford Press: London.
2. Lewis, C. M., Levinson, D. F., Wise, L. H., DeLisi, L. E., Straub, R. E., Hovatta, I., et al. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder. II. Schizophrenia. American Journal of Human Genetics, 73, 34-48.
3. Lewis, S. W., & Murray, R. M. (1987). Obstetric complications, neurodevelopmental deviance and risk of schizophrenia. Journal of Psychiatric Research, 21, 414-421.
4. Liddle, P. (1987). The symptoms of chronic schizophrenia: A reexamination of the positive-negative dichotomy. British Journal of Psychiatry, 151, 145-151.
5. Liddle, P., & Pantelis, C. (2003). Brain imaging in schizophrenia. In S. R. Hirsch, & D. R. Weinberger (Eds.), Schizophrenia (2nd edn.). Oxford: Blackwell.
6. Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353, 1209-1223.
7. Lindsay, J., Ounsted, C., & Richards, P. (1979). Long-term outcome of children with temporal lobe seizures. II. Marriage, parenthood and sexual indifference. Developmental Medicine and Child Neurology, 21, 433-440.
8. Loebel, A. D., Lieberman, J. A., Alvir, J. M., Mayerhoff, D. I., Geisler, S. H., & Szymanski, S. R. (1992). Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry, 149, 1183-1188.
9. Maj, M. (1998). Critique of the DSM-IV operational diagnostic criteria for schizophrenia. British Journal of Psychiatry, 172, 458-460.
10. Marquardt, R. K., Levitt, J. G., Blanton, R. E., Caplan, R., Asarnow, R., Siddarth, P., et al. (2005). Abnormal development of the anterior cingulate in childhood-onset schizophrenia: A preliminary quantitative MRI study. Psychiatry Research, 138, 221-233.
11. Mason, P., Harrison, G., Croudace, T., Glazebrook, C., & Medley, I. (1997). The predictive validity of a diagnosis of schizophrenia. British Journal of Psychiatry, 170, 321-327.
12. Matsumoto, H., Takei, N., Saito, H., Kachi, K., & Mori, N. (1999). Childhood-onset schizophrenia and obstretic complications: A case-control study. Schizophrenia Research, 38, 93-99.
13. Matsumoto, H., Takei, N., Saito, H., Kachi, K., & Mori, N. (2001). The association between obstretric complications and childhoodonset schizophrenia: A replication study. Psychological Medicine, 31, 907-914.
14. McGlashan, T. H., & Hoffman, R. E. (2000). Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Archives of General Psychiatry, 57, 637-648.
15. McGrath, J., & Murray, R. (1995). Risk factors for schizophrenia: from conception to birth. In S. R. Hirsch, & D. R. Weinberger (Eds.), Schizophrenia (pp. 187-205). Oxford: Blackwell Science.
16. McGorry, P. D., Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S., Cosgrave, E. M., et al. (2002). Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59, 921-928.
17. Mirnics, K., Middleton, F. A., Lewis, D. A., & Levitt, P. (2001). Analysis of complex brain disorders with gene expression microarrays: Schizophrenia as a disease of the synapse. Trends in Neuroscience, 24, 479-486.
18. Morgan, C., & Fisher, H. (2007). Environmental factors in schizophrenia: Childhood trauma. Schizophrenia Bulletin, 33, 3-10.
19. National Institute for Clinical Excellence (NICE). (2002). Guidance on the use of newer (atypical) antipsychotic drugs for the treatment of schizophrenia. NICE Technology Appraisal Guidance No. 43. London: NICE.
20. Nelson, M. D., Saykin, A. J., Flashman, L. A., & Riodan, H. J. (1998). Hippocampal volume reduction in schizophrenia assessed by magnetic resonance imaging: A meta-analytic study. Archives of General Psychiatry, 55, 433-440.
21. Nicolson, R. M., Giedd, J. N., Lenane, M., Hamburger, S., Singaracharlu, S., Bedwell, J., et al. (1999). Clinical and neurobiological correlates of cytogenetic abnormalities in childhood-onset schizophrenia. American Journal of Psychiatry, 156, 1575-1579.
22. Nopoulos, P., Torres, I., Flaum, M., Andreasen, N. C., Ehrhaerdt, J. C., & Yuh, W. T. C. (1995). Brain morphology in first-episode schizophrenia. American Journal of Psychiatry, 152, 1721-1723.
23. Nopoulos, P. C., Giedd, J. N., Andreasen, N. C., & Rapoport, J. L. (1998). Frequency and severity of enlarged septi pellucidi in childhood-onset schizophrenia. American Journal of Psychiatry, 155, 1074-1079.
24. O'Driscoll, G. A., Benkelfat, C., Florencio, P. S., Wolff, A. L., Joober, R., Lal, S., et al. (1999). Neural correlates of eye tracking deficits in first-degree relatives of schizophrenic patients: A positron emission tomography study. Archives of General Psychiatry, 56, 1127-1134.
25. Owen, M. J, Craddock, N., & O'Donovan, M. C. (2005). Schizophrenia: Genes at last? Trends in Genetics, 21, 518-525.
26. Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., et al. (2003). Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet, 361, 281-288.
27. Park, S., Holzman, P. S., & Goldman-Rakic, P. S. (1995). Spatial working memory deficits in the relatives of schizophrenic patients. Archives of General Psychiatry, 52, 821-828.
28. Perlstein, W. M., Carter, C. S., Noll, D. C., & Cohen, J. D. (2001). Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. American Journal of Psychiatry, 158, 1105-1113.
29. Pennington, B. F. (1997). Dimensions of executive functions in normal and abnormal velopment. In N. Krasnegor, G. R. Lyon, & P. S. Goldman-Rakic (Eds.), Prefrontal cortex: Evolution, development, and behavioral neuroscience (pp. 265-281). Baltimore: Brooke Publishing.
30. Pettegrew, J. W., Keshavan, M. S., Panchalingam, K., Strychor, S., Kaplan, D. B., Tretta, M. G., et al. (1991). Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics: A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Archives of General Psychiatry, 48, 563-568.
31. Pistis, M., Perra, S., Pillolla, G., Melia, M., Muntoni, A. L., & Gessa, G. L. (2004). Adolescent exposure to cannabinoids induces longlasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biological Psychiatry, 56, 86-94.
32. Pool, D., Bloom, W., Miekle, D. H., Roniger, J. J., & Gallant, D. M. (1976). A controlled trial of loxapine in 75 adolescent schizophrenic patients. Current Therapeutic Research, 19, 99-104.
33. Poole, R., & Brabbins, C. (1996). Drug induced psychosis. British Journal of Psychiatry, 168, 135-138.
34. Poulton, R., Caspi, A., Moffitt, T. E., Cannon, M., Murray, R., & Harrington, H. (2000). Children's self-reported psychotic symptoms and adult schizophreniform disorder: A 15-year longitudinal study. Archives of General Psychiatry, 57, 1053-1058.
35. Purves, D. L., & Lichtmen, J. W. (1980). Elimination of synapses in the developing nervous system. Science, 210, 153-157.
36. Rapoport, J. L., Addington, A. M., & Frangou, S. (2005). The neurodevelopmental model of schizophrenia: Update, 2005. Molecular Psychiatry, 10, 434-449.
37. Rapoport, J. L., Conners, C., & Reatig, N. (1985). Rating scales and assessment instruments for use in paediatric psychopharmacology research. Psychopharmacology Bulletin, 21, 1077-1080.
38. Rapoport, J. L., Giedd, J., Blumenthal, J., Hamburger, S., Jeffries, N., Fernandez, T., et al. (1999). Progressive cortical change during adolescence in childhood-onset schizophrenia: A longitudinal magnetic resonance imaging study. Archives of General Psychiatry, 56, 649-654.
39. Ratzoni, G., Gothelf, D., Brand-Gothelf, A., Reidman, J., Kikinzon, L., Gal, G., et al. (2002). Weight gain associated with olanzapine and risperidone in adolescent patients: A comparative prospective study. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 337-343.
40. Read, J., van Os, J., Morrison, A. P., & Ross, C. A. (2005). Childhood trauma, psychosis and schizophrenia: A literature review with theoretical implications. Acta Psychiatrica Scandinavica, 112, 330-350.
41. Reich, W. (2000). Diagnostic Interview for Children and Adolescents (DICA). Journal of the American Academy of Child and Adolescent Psychiatry, 39, 59-66.
42. Reichenberg, A., Weiser, M., Rapp, M. A., Rabinowitz, J., Caspi, A., Schmeidler, J., et al. (2005). Elaboration on Premorbid Intellectual Performance in Schizophrenia: Premorbid Intellectual Decline and Risk for Schizophrenia. Arch Gren Psychiatry, 62, 1297-1304.
43. Remschmidt, H., Schultz, E., & Martin, M. (1994). An open trial of clozapine with thirty-six adolescents with schizophrenia. Journal of Child and Adolescent Psychopharmacology, 4, 31-41.
44. Roberts, G. W., Colter, N., Lofthouse, R., Bogerts, B., Zech, M., & Crow, T. J. (1986). Gliosis in schizophrenia: A survey. Biological Psychiatry, 21, 1043-1050.
45. Robinson, D., Woerner, M. G., Alvir, J. M., Bilder, R., Goldman, R., Geisler, S., et al. (1999). Predictors of relapse following a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry, 56, 241-247.
46. Rossi, A., Mancini, F., Stratta, P., Mattei, P., Gismondi, R., Pozzi, F., et al. (1997). Risperidone, negative symptoms and cognitive deficit in schizophrenia: An open study. Acta Psychiatrica Scandinavica, 95, 40-43.
47. Russell, A. T., Bott, L., & Sammons, C. (1989). The phenomena of schizophrenia occurring in childhood. Journal of the American Academy of Child and Adolescent Psychiatry, 28, 399-407.
48. Rutter, M., & Plomin, R. (1997). Opportunities for psychiatry from genetic findings. British Journal of Psychiatry, 171, 209-219.
49. Sachdev, P. (1998). Schizophrenia-like psychosis and epilepsy: The status of the association. American Journal of Psychiatry, 155, 325-336.
50. Saykin, A. J., Shtasel, D. L., Gur, R. E., Kester, D. B., Mozley, L. H., Stafiniak, P., et al. (1994). Neuropsychological deficits in neurolepticnaive patients with first-episode schizophrenia. Archives of General Psychiatry, 51, 124-131.
51. Schaeffer, J. L., & Ross, R. G. (2002). Childhood-onset schizophrenia: Premorbid and prodromal diagnostic and treatment histories. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 538-545.
52. Schmidt, M., Blanz, B., Dippe, A., Koppe, T., & Lay, B. (1995). Course of patients diagnosed as having schizophrenia during first episode occurring under age 18 years. European Archives of Psychiatry and Clinical Neuroscience, 245, 93-100.
53. Selemon, L. D., Rajkowska, G., & Goldman-Rakic, P. S. (1995). Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17. Archives of General Psychiatry, 52, 805-818.
54. Shaffer, D., Gould, M. S., Brasic, J., Ambrosini, P., Fisher, P., Bird, H., et al. (1983). The Children's Global Assessment Scale (CGAS). Archives of General Psychiatry, 40, 1228-1231.
55. Sikich, L., Hamer, R. M., Bashford, R. A., Sheitman, B. B., & Lieberman, J. A. (2004). A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: A double-blind, randomized, 8-week trial. Neuropsychopharmacology, 29, 133-145.
56. Simpson, G., & Angus, J. S. W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica, 212, 9-11.
57. Slaveska, K., Hollis, C. P., & Bramble, D. (1998). The use of antipsychotics by the child and adolescent psychiatrists of Trent region. Psychiatric Bulletin, 22, 685-687.
58. Spencer, E. K., & Campbell, M. (1994). Children with schizophrenia: Diagnosis, phenomenology and pharmacotherapy. Schizophrenia Bulletin, 20, 713-725.
59. Sporn, A. L., Addington, A. M., Gogtay, N., Ordonez, A. E., Gornick, M., Clasen, L., et al. (2004a). Pervasive developmental disorder and childhood-onset schizophrenia: Co-morbid disorder or phenotypic variant of a very early onset illness? Biological Psychiatry, 55, 989-994.
60. Sporn, A. L., Addington, A. M., Reiss, A. L., Dean, M., Gogtay, N., Potocnik, U., et al. (2004b). 22q11 deletion syndrome in childhoodonset schizophrenia: An update. Molecular Psychiatry, 9, 225-226.
61. Sporn, A. L., Greenstein, D., Gogtay, N., Jeffries, N. O., Lenane, M., Gochman, P., et al. (2003). Progressive brain volume loss during adolescence in childhood-onset schizophrenia. American Journal of Psychiatry, 160, 1281-1289.
62. Sporn, A. L., Greenstein, D., Gogtay, N., Sailer, F., Hommer, D. W., Rawlings, R., et al. (2005). Childhood-onset schizophrenia: Smooth pursuit eye-tracking dysfunction in family members. Schizophrenia Research, 73, 243-252.
63. St. Clair, D., Xu, M., Wang, P., Yu, Y., Fang, Y., Zhang, F., et al. (2005). Rates of adult schizophrenia following prenatal exposure to the Chinese Famine of 1959-1961. Journal of the American Medical Association, 294, 557-562.
64. Stayer, C., Sporn, A., Gogtay, N., Tossell, J. W., Lenane, M., Gochman, P., et al. (2005). Multidimensionally impaired: The good news. Journal of Child and Adolescent Psychopharmacology, 15, 510-519.
65. Strandburg, R. J., Marsh, J. T., Brown, W. S., et al. (1999). Continuous-processing ERPS in adult schizophrenia: Continuity with childhood-onset schizophrenia. Biological Psychiatry, 45, 1356-1369.
66. Susser, E., & Lin, S. P. (1992). Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. Archives of General Psychiatry, 49, 983-988.
67. Tarrier, N., Beckett, R., Harwood, S., Baker, A., Yusupoff, L., & Ugarteburu, I. (1993). A trial of two cognitive-behavioural methods of treating drug-resistant residual psychotic symptoms in schizophrenic patients. I. Outcome. British Journal of Psychiatry, 162, 524-532.
68. Thomas, M. A., Ke, Y., Levitt, J., Caplan, R., Curran, J., Asarnow, R., et al. (1998). Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia. Journal of Magnetic Resonance Imaging, 8, 841-846.
69. Theisen, F. M., Linden, A., Geller, F., Schafer, H., Martin, M., Remschmidt, H., et al. (2001). Prevalence of obesity in adolescent and young adult patients with and without schizophrenia and in relationship to antipsychotic medication. Journal of Psychiatric Research, 35, 339-345.
70. Toren, P., Ratner, S., Laor, N., & Weizman, A. (2004). Benefit-risk assessment of atypical antipsychotics in the treatment of schizophrenia and comorbid disorders in children and adolescents. Drug Safety, 27, 1135-1156.
71. Towbin, K. R., Dykens, E. M., Pearson, G. S., & Cohen, D. J. (1993). Conceptualizing "borderline syndrome of childhood" and "childhood schizophrenia" as a developmental disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 775-782.
72. Tsuang, M. T., Simpson, J. C., & Kronfold, Z. (1982). Subtypes of drug abuse with psychosis. Archives of General Psychiatry, 39, 141-147.
73. Turkington, D., & Kingdon, D. (2000). Cognitive-behavioural techniques for general psychiatrists in the management of patients with psychoses. British Journal of Psychiatry, 177, 101-106.
74. Vita, A., Dieci, M., Giobbio, G. M., Azzone, P., Garbarini, M., Sacchetti, E., et al. (1991). CT scan abnormalities and outcome of chronic schizophrenia. American Journal of Psychiatry, 148, 1577-1579.
75. Volkmar, F. R., & Cohen, D. J. (1991). Comorbid association of autism and schizophrenia. American Journal of Psychiatry, 148, 1705-1707.
76. Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660-669.
77. Werry, J. S., McClellan, J. M., & Chard, L. (1991). Childhood and adolescent schizophrenia, bipolar and schizoaffective disorders: A clinical and outcome study. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 457-465.
78. Werry, J. S., McClellan, J. M., Andrews, L., & Ham, M. (1994). Clinical features and outcome of child and adolescent schizophrenia. Schizophrenia Bulletin, 20, 619-630.
79. White, T., Andreasen, N. C., Nopoulos, P., & Magnotta, V. (2003). Gyrification abnormalities in childhood-onset schizophrenia. Biological Psychiatry, 54, 418-426.
80. Woods, B. T. (1998). Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. American Journal of Psychiatry, 155, 1661-1670.
81. World Health Organization. (1996). Multiaxial classification of child and adolescent psychiatric disorders: The ICD-10 classification of mental and behavioural disorders in children and adolescents. Cambridge, UK: Cambridge University Press.
82. Wyatt, R. J. (1995). Early intervention in schizophrenia: can the course be altered? Biological Psychiatry, 38, 1-3.
83. Wykes, T., Reeder, C., Williams, C., Corner, J., Rice, C., & Everitt, B. (2000). Cognitive remediation: Predictors of success and durability of improvements (Abstract). Schizophrenia Research, 41, 221.
84. Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M., et al. (2003). Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophrenia Research, 60, 21-32.
85. Zahn, T. P., Jacobsen, L. K., Gordon, C. T., McKenna, K., Frazier, K., & Rapoport, J. L. (1997). Autonomic nervous system markers of psychopathology in childhood-onset schizophrenia. Archives of General Psychiatry, 54, 904-912.
86. Zahn, T. P., Jacobsen, L. K., Gordon, C. T., McKenna, K., Frazier, K., & Rapoport, J. L. (1998). Attention deficits in childhood-onset schizophrenia: Reaction time studies. Journal of Abnormal Psychology, 107, 97-108.